Bellicum Pharma (BLCM) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts BLCM Hot Sheet
Join SI Premium – FREE
Bellicum Pharma (NASDAQ: BLCM) reported Q2 EPS of ($0.61), $0.04 worse than the analyst estimate of ($0.57).
For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Morgan Stanley upgrades Synopsys as it turns selective on chip stocks
- Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
